866-997-4948(US-Canada Toll Free)

Pathological Gambling Global Clinical Trials Review, H2, 2015

Published By :

GlobalData

Published Date : Dec 2015

Category :

Pharmaceutical

No. of Pages : 40 Pages

Pathological Gambling Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, Pathological Gambling Global Clinical Trials Review, H2, 2015" provides an overview of Pathological Gambling clinical trials scenario. This report provides top line data relating to the clinical trials on Pathological Gambling. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Central and South America 11
Clinical Trials by G7 Countries: Proportion of Pathological Gambling to Central Nervous System Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Pathological Gambling to Central Nervous System Clinical Trials 15
Clinical Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Pathological Gambling Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profile Snapshots 24
Appendix 37
Abbreviations 37
Definitions 37
Research Methodology 38
Secondary Research 38
About GlobalData 39
Contact Us 39
Disclaimer 39
Source 40

List of Tables
Pathological Gambling Therapeutics, Global, Clinical Trials by Region, 2015* 5
Pathological Gambling Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Pathological Gambling Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Pathological Gambling Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 9
Pathological Gambling Therapeutics Clinical Trials, North America, Top Countries, 2015* 10
Pathological Gambling Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 11
Proportion of Pathological Gambling to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 12
Pathological Gambling Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Pathological Gambling Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Pathological Gambling to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 15
Pathological Gambling Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Pathological Gambling Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Pathological Gambling Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Pathological Gambling Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Pathological Gambling Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 20
Pathological Gambling Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Pathological Gambling Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Pathological Gambling Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23

List of Figures
Pathological Gambling Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
Pathological Gambling Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Pathological Gambling Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Pathological Gambling Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 9
Pathological Gambling Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 10
Pathological Gambling Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 11
Proportion of Pathological Gambling to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 12
Pathological Gambling Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Pathological Gambling Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Pathological Gambling to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 15
Pathological Gambling Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Pathological Gambling Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Pathological Gambling Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Pathological Gambling Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Pathological Gambling Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 20
Pathological Gambling Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Pathological Gambling Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Pathological Gambling Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
GlobalData Methodology 38

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports